Guangzhou LBP Medicine Science & Technology Balans Gezondheid

Financiële gezondheid criteriumcontroles 0/6

Belangrijke informatie

0.7%

Verhouding schuld/eigen vermogen

CN¥8.85m

Schuld

Rente dekkingsratio	-0.4x
Contant	CN¥110.05m
Aandelen	CN¥1.25b
Totaal verplichtingen	CN¥125.71m
Totaal activa	CN¥1.38b

Recente financiële gezondheidsupdates

Geen updates

Recent updates

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Problems Go Beyond Poor Profit

Nov 06

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) Shares May Have Run Too Fast Too Soon

Sep 30

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture

Apr 29

Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%

Apr 23

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) 31% Price Boost Is Out Of Tune With Earnings

Mar 09

Guangzhou LBP Medicine Science & Technology Balans Gezondheid

Financiële gezondheid criteriumcontroles 0/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Recent updates

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Problems Go Beyond Poor Profit

Third quarter 2024 earnings released: EPS: CN¥0.16 (vs CN¥0.21 in 3Q 2023)

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report Q3, 2024 Results on Oct 31, 2024

Investor sentiment improves as stock rises 27%

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) Shares May Have Run Too Fast Too Soon

New minor risk - Earnings quality

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report First Half, 2024 Results on Aug 30, 2024

Guangzhou LBP Medicine Science & Technology's (SHSE:688393) Weak Earnings May Only Reveal A Part Of The Whole Picture

Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.46 in FY 2022)

Guangzhou LBP Medicine Science & Technology Co., Ltd., Annual General Meeting, May 15, 2024

Some Confidence Is Lacking In Guangzhou LBP Medicine Science & Technology Co., Ltd. (SHSE:688393) As Shares Slide 25%

Investor sentiment deteriorates as stock falls 18%

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report Q1, 2024 Results on Apr 30, 2024

Investor sentiment improves as stock rises 19%

Guangzhou LBP Medicine Science & Technology Co., Ltd.'s (SHSE:688393) 31% Price Boost Is Out Of Tune With Earnings

Full year 2023 earnings released: EPS: CN¥0.43 (vs CN¥0.46 in FY 2022)

New minor risk - Share price stability

Investor sentiment deteriorates as stock falls 19%

Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.09 in 3Q 2022)

Less than half of directors are independent

Investor sentiment deteriorates as stock falls 21%

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report First Half, 2023 Results on Aug 15, 2023

Full year 2022 earnings released: EPS: CN¥0.46 (vs CN¥0.85 in FY 2021)

Investor sentiment improves as stock rises 19%

Full year 2022 earnings released: EPS: CN¥0.47 (vs CN¥0.85 in FY 2021)

Investor sentiment improves as stock rises 16%

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: CN¥0.09 (vs CN¥0.25 in 3Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.29 in 1Q 2021)

Full year 2021 earnings released: EPS: CN¥0.86 (vs CN¥1.09 in FY 2020)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.25 (vs CN¥0.43 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.26 (vs CN¥0.33 in 2Q 2020)

Investor sentiment improved over the past week

Full year 2020 earnings released: EPS CN¥1.09 (vs CN¥1.06 in FY 2019)

New 90-day low: CN¥34.43

New 90-day low: CN¥39.97

New 90-day low: CN¥42.73

Third quarter earnings released

Guangzhou LBP Medicine Science & Technology Co., Ltd. to Report Q3, 2020 Results on Oct 22, 2020

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Ontdek gezonde bedrijven